Navigation Links
Gene Therapy Helps To Cure 'Incurable' Illness

The immune systems of two men who were born with an "incurable" genetic disorder that made them almost defenceless against bacterial and fungal infections has been repaired with Gene therapy. // Sixteen months after an operation to repair a defective gene, the once severely ill patients show signs of complete recovery, a German-based team of scientists said Sunday. Scientists believe that this latest success will lead to further operations for treating other such chronic and incurable conditions due to inheritance of defective genes. These cutting-edge techniques have mainly been used in the past to help sick children. Dorothee von Laer, gene therapy coordinator at the Georg Speyer laboratory in Frankfurt, said two males, aged 25 and 26, had been treated for a hereditary autoimmune disease over the past two years at Frankfurt University Hospital. She said the new technique might prove suitable for other diseases where people are born with a defective gene. Gene therapy is a procedure involving the alteration of a person's genome to repair or replace a mutated gene. After years research, the technique has finally seems to have proven its potential with a handful of successful operations. The treatment of two men with chronic granulomatous disorder (CGD) is the latest success. The men suffered repeated life-threatening infections from bacteria and fungi from an early age had to rely on powerful antibiotics and antifungal medicines. After their operations 16 months ago, both patients have gained weight and have been free of the severe infections that have plagued them since childhood. Manual Grez of the Institute for Biomedical Research in Frankfurt, one of the leaders of the study published in the journal Nature Medicine, said the results suggest that it may be possible to use gene therapy to treat other similar inherited diseases. Stating that the work was a landmark study he said that though the results are very positive there still has to be a lot of wor k to make this technology available to all patients. Chronic granulomatous disorder (CGD) is a rare immunodeficiency disease caused by a defective gene on the maternally inherited X chromosome. In this condition their bodies cannot kill invading bacteria and fungi and they often have internal infections. Currently the disease is treated using bone-marrow transplants. The new technique involved the scientists to take blood stem cells from the men and introduced a healthy gene to the cells. The cells were then re-injected into the men. The key to the technique was a new, more efficient method of inserting the genes in many cells at the same time. Concern remains that such therapy could have a negative side effect like causing cancer of the blood. Research is continuing on how to make such techniques safer. Professor Adrian Thrasher of the Great Ormond Street Hospital in London says that further improvements and refinements in the technology are now being done and studied so as to maximise the effectiveness and safety of the system.
'"/>




Related medicine news :

1. Cancer Doctors Okays Controversial Prostate Therapy
2. Consensus on "Combination Therapy" for Breast Cancer
3. Gene Therapy shows promise in treating Hemophilia
4. "Make AIDS Therapy affordable" - Physicians demand
5. Hormone replacement Therapy a headache
6. Simple Therapy
7. Therapy for stopping the spread of cancer cells
8. Gene Therapy Destroys Pancreatic Cancer Cells
9. Letrozole Beats Tamoxifen in Breast Cancer Therapy
10. Garlic Supplements Impede HIV Therapy
11. Gene Therapy For Cystic Fibrosis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica Scruggs ... for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs surgery, ... Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, MD, ...
(Date:6/25/2016)... Oklahoma City, Oklahoma (PRWEB) , ... June 25, ... ... to helping both athletes and non-athletes recover from injury. Recently, he has implemented ... for the Oklahoma City area —Johnson is one of the first doctors to ...
(Date:6/24/2016)... ... , ... June 19, 2016 is World Sickle Cell Observance Day. In an ... of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a ... Cell Disease (SCD) is a disorder of the red blood cells, which can cause ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San ... Society and the Road To Recovery® program to drive cancer patients to and from ... adults to ensure the highest quality of life and ongoing independence. Getting to ...
(Date:6/24/2016)... Vegas, Nevada (PRWEB) , ... June 24, 2016 ... ... Las Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and processing ... Grove, in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
Breaking Medicine Technology: